Related Experiment Video
Updated: Jul 14, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Current treatment strategies for multiple myeloma
Sheeba Thomas1, Raymond Alexanian
1Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Recent advances in multiple myeloma treatment, including novel drug combinations and stem cell transplantation, show high response rates. However, disease relapse remains a challenge, driving research into new therapeutic strategies.
Area of Science:
- Hematology
- Oncology
- Clinical Therapeutics
Background:
- Multiple myeloma treatment has seen significant progress.
- Current therapies offer high response rates for previously untreated patients.
Purpose of the Study:
- To summarize recent advances in multiple myeloma treatment.
- To highlight the efficacy of current therapeutic strategies and ongoing research.
Main Methods:
- Review of recent clinical studies and treatment outcomes.
- Analysis of response rates, remission durations, and survival data.
- Discussion of novel agents and combination therapies under investigation.
Main Results:
- Dexamethasone, lenalidomide, thalidomide, and bortezomib combinations yield 80%-90% overall response rates.
- High-dose chemotherapy with autologous stem cell transplantation improves survival in younger patients.
- Maintenance therapy can extend remissions for patients not undergoing transplantation.
Conclusions:
- Current treatments significantly improve outcomes in multiple myeloma.
- Stem cell transplantation and maintenance therapies are key for prolonged remission.
- Relapse remains a challenge, necessitating continued research into novel treatment strategies.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
